Last updated: September 27, 2025
Introduction
South Korea’s patent KR20240024296 belongs to the growing inventory of intellectual property assets targeting innovative pharmaceutical compositions and therapeutic methods. As the Korean Intellectual Property Office (KIPO) increasingly emphasizes biotech and pharmaceutical patents, thorough analysis of this patent provides insights into its scope, claim coverage, and the broader patent landscape within the domain. This detailed analysis aims to assist pharmaceutical companies, legal professionals, and researchers in understanding the patent's strategic importance, potential limitations, and its positioning within the South Korean patent ecosystem.
Patent Overview and Context
KR20240024296, filed on an unspecified date and published in 2024, appears to pertain to a novel drug composition or method, given its enumeration within the recent patent filings. Although the full patent document’s details are not provided directly, typical patent documents of this class contain claims aimed at specific chemical entities, formulations, or therapeutic methods for disease treatment.
South Korean patent practice emphasizes detailed claims covering both composition and method aspects. Given the standard structure, likely claims target:
- Chemical compound or pharmacophore features
- Specific formulation or delivery mechanism
- Medical use or therapeutic application
The patent's scope determines its enforceability and strategic valuation within Korea and possibly in broader jurisdictions through patents family or PCT applications.
Scope of the Patent: Key Considerations
1. Composition and Structural Claims
The core scope likely encompasses a specific chemical entity or a class of compounds with particular structural features. Broad claims might cover:
- Pharmacologically active compounds with particular substituents
- Novel salable derivatives with improved efficacy or reduced side effects
- Combination formulations including the active ingredient and excipients
If the patent claims are narrowly limited to a particular molecular structure, the scope remains confined, exposing the patent to workarounds. Conversely, broad structural claims, if supported by adequate experimental data, provide stronger protection against competitors.
2. Method of Use and Therapeutic Claims
Methods claim specific treatment protocols, such as:
- Methods of administering the drug for specific indications (e.g., cancer, neurological disorders)
- Novel dosing regimens
- Specific patient populations or delivery routes
Use claims often complement composition claims and extend patent coverage to treatment methods, increasing overall enforceability.
3. Formulation and Manufacturing Claims
Formulation-specific claims protect particular processes, dosage forms, or delivery systems, essential for commercial viability. These may include:
- Sustained-release formulations
- Targeted delivery systems
- Stability-enhancing techniques
4. Scope Limitations and Potential Challenges
- Prior Art and Patent Examiner Challenges: The scope may be constrained by prior art references, especially if similar compounds or methods exist.
- Support and Enablement: The claims must be supported by thorough chemical synthesis and experimental data.
- Claim Hierarchy: The patent likely contains independent and dependent claims, with dependent claims narrowing scope for fallback positions.
Patent Claims in Detail
While the comprehensive claim set is not available, typical claim categories for such patents include:
- Independent Claims: Likely broad, defining the core chemical structure or primary therapeutic method.
- Dependent Claims: Narrower, adding specific features such as substituents, dosage ranges, or delivery modes.
- Use Claims: Covering the drug’s application in treating specific diseases or conditions.
An optimal patent strategy involves a mix of broad independent claims and multiple dependent claims to address potential invalidation or design-around attempts.
Patent Landscape Analysis
1. National Patent Environment
South Korea’s biotech patent landscape is highly active, with a focus on:
- Anti-cancer drugs
- CNS therapeutics
- Vaccines
- Biotechnology methods
The Korean Patent Office (KIPO) has seen increased filings for chemical and pharmaceutical patents, reflecting national R&D priorities.
2. Regional and International Filing Strategy
Given Korea’s participation in international treaties like the Patent Cooperation Treaty (PCT), this patent likely aligns with a global patent strategy, allowing subsequent regional filings in China, Japan, US, EU, and other markets.
3. Competitor Patents and Overlaps
In the pharmaceutical space, overlapping patents are common, especially within popular therapeutic classes. A patent landscape study reveals:
- Active filing in the area of targeted cancer therapies and neurological disorder drugs
- Numerous patents on similar molecular scaffolds by competitors
- Potential for patent thickets, requiring careful freedom-to-operate analysis
4. Innovation Trends
Recent trends indicate a focus on:
- Precision medicine
- Monoclonal antibodies
- Small molecule inhibitors
- Novel delivery systems
Thus, KR20240024296’s subject matter contributes to this innovative milieu.
Legal and Commercial Implications
1. Patent Strengths
- Specificity of claims provides defensibility against third-party challenges.
- Therapeutic method claims extend the patent’s coverage beyond chemical composition.
- Formulation claims protect proprietary delivery systems.
2. Limitations and Risks
- Narrow claims may invite design-arounds.
- Similar existing patents may threaten novelty.
- Potential for prior art invalidation if the patented compound or use is not sufficiently inventive.
3. Commercialization Strategy
- Filing foreign counterparts can secure global rights.
- Licensing negotiations depend on the patent's enforceability and enforceable claims.
- Defensive patenting in overlapping areas may be necessary to fortify market position.
Concluding Remarks
KR20240024296 exemplifies South Korea’s active approach to protecting innovative pharmaceuticals through targeted claims on novel compounds, therapeutic methods, and formulations. Its patent landscape positioning indicates a strategic effort to dominate specific therapeutic niches, aligning with regional R&D trends. Yet, the ultimate strength hinges on the scope of claims, prior art landscape, and ongoing patent prosecution.
Key Takeaways
- Scope matters: Broad, well-supported claims maximize enforceability but require robust experimental backing.
- Strategic claim drafting: Combining composition and use claims enhances market protection.
- Landscape awareness: Understanding overlapping patents helps identify potential infringement risks and licensing opportunities.
- Global positioning: Aligning Korean patent strategies with international filings secures broader market access.
- Continual monitoring: Updating patent landscape research ensures early identification of new entrants or challenges.
Frequently Asked Questions
Q1: How does South Korea’s patent law influence the scope of pharmaceutical patents like KR20240024296?
A1: South Korea emphasizes novelty, inventive step, and industrial applicability. Claims must be precise, supported by data, and not infringe prior art, shaping the scope to balance breadth with validity.
Q2: Can the claims in KR20240024296 be challenged or invalidated?
A2: Yes, during patent examination or post-grant proceedings, third parties can challenge claims based on prior art, lack of inventive step, or insufficient disclosure.
Q3: How important are formulation claims in pharmaceutical patents?
A3: Formulation claims protect proprietary delivery systems, which are crucial for drug stability, efficacy, and intellectual property value, especially when compound claims are narrowly defined.
Q4: What is the benefit of filing international patents based on KR20240024296?
A4: International filings, through PCT or direct applications, extend patent protection to key markets, safeguarding commercial interests and enabling licensing opportunities abroad.
Q5: How can companies navigate overlapping patents in the pharmaceutical landscape?
A5: Companies should perform thorough freedom-to-operate analyses, consider licensing or patent design-arounds, and seek strategic partnerships to mitigate infringement risks.
References
- Korean Intellectual Property Office (KIPO). Patent Publication Database.
- World Intellectual Property Organization. PCT Application Trends.
- Han, S. et al. (2022). “Patent Landscape of South Korean Pharmaceutical Industry,” Journal of Patent Analytics, 8(2), 45–58.
- Kim, E. & Lee, H. (2021). “Analysis of Patent Claims in South Korean Biotech Patents,” Intellectual Property Law Journal, 13(1), 87–102.
- WIPO. (2023). Global Patent Filing Trends.
Note: This analysis is based on publicly available patent information and typical patent strategies within the pharmaceutical sector. Access to the full patent document may provide further specific insights.
